>>Description of the research protocol "EvoCit HD"

Dialysis adequacy and clotting complications during anticoagulation-free hemodialysis using a heparin-grafted dialyzer and a citrate-enriched dialysate: a prospective randomized cross over study. EvoCit-HD
Phase II study| Status : Ongoing and recruiting

Additional details

Indication (or studied pathology) : Néphro/dialyse
Brugmann identifier : EvoCit HD
EudraCT identifier : 2017-004884-11
ClinicalTrials.gov identifier : NCT03887468


Involved department : Nephrology-dialysis
Principal investigator : Collard
Sponsor : UZ
Contact : Clinical Research Unit

>This protocol was approved by the UZ Brussel ethics committee.